PeptidesFDA’s 503B GLP-1 Bulks Proposal: What It Would Exclude
FDA proposed not to place semaglutide, tirzepatide, or liraglutide on the 503B Bulks List. The proposal is not a final ban or drug recall.
Tag
4 articles
PeptidesFDA proposed not to place semaglutide, tirzepatide, or liraglutide on the 503B Bulks List. The proposal is not a final ban or drug recall.
PeptidesEMA’s medicines committee backed an oral Wegovy formulation in May 2026, and the European product record now lists both tablets and pre-filled pens for weight management.
PeptidesFDA revised Import Alert 66-80 on August 21, allowing detention without physical examination of certain GLP-1 bulk drug substances while maintaining a compliance-based Green List.
Fat BurningOverview of Semaglutide Semaglutide, known under brand names like Ozempic for diabetes treatment and Wegovy…
The community
The articles are the reference — the forum is where it gets real. Cycles, bloodwork, training logs, source talk.